argyrotsipi/train-dataset huggingface dataset:
Benefit Claimants Sanctions (Required Assessment) Bill — House of Commons, 2016-12-02
Topic: Health
Callum McCaig (Scottish National Party, Centre-left): I think the most powerful part of my hon. Friend’s speech is what she is saying about the impact on people’s mental health. We can look at the pounds and pence that the Government are saving through their measures, but they are storing up an immense problem. Who pays for that? It is the taxpayer. If we cannot appeal to Government Members’ humanity, at least we can appeal to their love of money.
Benefit Claimants Sanctions (Required Assessment) Bill — House of Commons, 2016-12-02
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): Over the last seven or eight years, pressures on the mental health services in this country have increased. It may not simply be that the sanctions regime is not saving money; the regime is likely to be costing money, because it is driving more people to require support.
Benefit Claimants Sanctions (Required Assessment) Bill — House of Commons, 2016-12-02
Topic: Health
Mhairi Black (Scottish National Party, Centre-left): The public are watching, and we owe a debt to Ken Loach for focusing our minds on the human costs. His film tells the story of a 59-year-old joiner from Newcastle, Daniel Blake, who suffers a heart attack at work.
Covid-19: Response — House of Lords, 2020-07-27
Topic: Health
James Bethell (Conservative, Centre-right): The noble Baroness invites speculation; I wish that I knew the precise answer to that key question. We are extremely vigilant in a large number of areas, including the measures to release a degree of social distancing and on foreign travel, as she knows. We know that if the country remains committed to the basic principles—hand washing and hygiene; social distance; and isolation when necessary—those three principal pillars will be the ones that defend us from the spread of the disease. We are doing everything we can to shore up those pillars, and that is particularly true in social care, where we have massively boosted testing for both staff and patients and brought in hygiene control, particularly around PPE. We will continue to support the sector financially to ensure that agency workers can be used as little as possible.
Covid-19: Response — House of Lords, 2020-07-27
Topic: Health
Janet Evelyn Fookes (Conservative, Centre-right): I will follow on from the question posed by the noble Baroness, Lady Watkins of Tavistock. Have the Government worked out an order of priority in which people might receive a vaccine? Would it be front-line workers, the elderly or even—perhaps—government Ministers?
Covid-19: Response — House of Lords, 2020-07-27
Topic: Health
James Bethell (Conservative, Centre-right): The noble Lord touches on a subject that is extremely sensitive—it makes me feel emotional to think about it—but he is entirely right that those who are least advantaged in society are hardest hit by this disease and lots of other diseases. There are behavioural reasons for this: the decisions that people make about social distancing and their own health. There are also environmental reasons: the living conditions and the places in which they live. Neither of these detract from the fact that this is a very sad and upsetting truth. However, we are extremely conscious of the challenge, as we are of all health inequalities. The particular lever that we are focused on is trying to get our message out to hard-to-reach communities, who may not have heard the important messages on hygiene, social distancing and isolation. We have in place a programme of marketing in order to reach these communities to communicate these important messages.
Covid-19: Response — House of Lords, 2020-07-27
Topic: Health
Bernard Francisco Ribeiro (Conservative, Centre-right): My Lords, the London Nightingale hospital was mothballed in mid-May and remains at standby for a second wave of Covid-19, having treated just 54 patients since it opened on 3 April. In a recent report of 19 July, Harrogate Borough Council questioned how the 500-bed field hospital based in Harrogate Convention Centre would be deployed. Given that £3 billion has been allocated to maintain the seven Nightingale hospitals until the end of March 2021, and noting that the Harrogate centre has not treated a single patient since it opened, can my noble friend the Minister say what the strategy is for those hospitals? Should they not be designated Covid centres to which all local hospitals can refer their patients, thereby allowing the NHS to resume its routine work and centres such as the London Nightingale hospital, which could reopen in six days with 250 beds, to provide assisted ventilation, hemofiltration and dialysis to support seriously ill Covid patients?
Aleppo — House of Commons, 2016-11-28
Topic: Defense
Joanna Catherine Cherry (Scottish National Party, Centre-left): In the letter of the hon. Member for Wirral South (Alison McGovern), whom I congratulate on her work on this issue, she points out that the Government said back in May: "preparations for airdrops will now take place and go forward rapidly because there isn’t a moment to lose" The situation has worsened significantly since May, so I do not understand what has happened to that enthusiasm. More importantly, my constituents, and those of other Members, are appalled by what they see on the news and do not understand why there is not the same enthusiasm for airdrops as there was for bombing this time last year.
Covid-19 Update — House of Lords, 2020-12-15
Topic: Health
James Bethell (Conservative, Centre-right): I thank my noble friend for providing this opportunity to scotch that unhelpful rumour. I confirm that there are absolutely no animal components in the vaccine. That point has been endorsed by the British Islamic Medical Association, members of which issued a fatwa earlier this year confirming that the vaccine was halal. My noble friend is right that there are stories on social media that are extremely distracting. We engage with sympathy with those who are concerned about the vaccine, but these stories are completely wrong, and I would like to put them to bed.
Covid-19 Update — House of Lords, 2020-12-15
Topic: Health
James Bethell (Conservative, Centre-right): If I have heard the question correctly, that is exactly how the test release scheme works. Travellers are invited to sign the appropriate forms and after some days they can be released from isolation early by taking tests. That scheme has been signed off by the Chief Medical Officer and data from the test is transmitted to Public Health England. We currently have a UK-only testing regime and we do not take tests from overseas, but we are keeping the scheme under review.
Coronavirus Vaccine — House of Lords, 2020-12-03
Topic: Health
James Bethell (Conservative, Centre-right): My Lords, in relation to the logistical nightmare, one of the nice things about vaccines is that they do not take up much space: they are relatively compact, so I am not sure that wide-bodied aircraft will be needed, but I thank the noble Viscount for the wise suggestion. In relation to certification, he raises an interesting prospect that we have not fully bottomed out yet. As I said in response to earlier questions, we do not know whether vaccination will reduce transmissibility. Our hope and expectation are that it will, but until that is proven, any thoughts of certification will be premature.
Points of Order — House of Commons, 2016-11-23
Topic: Defense
Christopher Charles Stephens (Scottish National Party, Centre-left): On a point of order, Mr Speaker. In the strategic defence and security review last year, it was reported that the national shipbuilding strategy and the Government’s response to it would be published by the time of the autumn statement. Sadly, the strategy and the report have not yet been published. Have you, Mr Speaker, received any indication from any Minister from the Ministry of Defence whether they will make a statement today on the industry, which is iconic and highly skilled and which affects many of my constituents?
NHS Funding — House of Commons, 2016-10-31
Topic: Health
Martyn Day (Scottish National Party, Centre-left): With some 80% of trusts in deficit and only 4% meeting accident and emergency targets, I am grateful to the Health Committee for flagging up the dire financial state of the NHS in England, as evidenced by its letter to the Chancellor. We learn from that document that the £10 billion figure is a bit of a fallacy. In Scotland, the SNP Government are committed to investing an additional £2 billion by 2021, but any reduction in new money for the NHS from the UK Government would have an impact on Barnett consequentials. Given that the UK Government have already slashed Scotland’s budget by 10% between 2010 and 2020, they need to be honest and transparent about what that reduction will mean for Scotland’s funding. With the Department of Health having accidentally not adjusted its books for an extra £417 million from national insurance contributions, and having broken its control total by £207 million, will the devolved Governments get any share of that additional £624 million?
UK-EU Future Relationship Negotiations and Transition Period — House of Lords, 2020-12-08
Topic: Health
Nicholas True (Conservative, Centre-right): My Lords, the continuing Covid emergency is obviously a problem, although I am sure that the noble Viscount will join me in welcoming the wonderful news of the first vaccination happening today. We continue to keep the impact of coronavirus on the delivery of the transition programme, as well as the potential for disruption, under review. We are considering, as we always do, what mitigations may be needed as the situation evolves.
Health Service Medical Supplies (Costs) Bill — House of Commons, 2016-10-24
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): Like the right hon. Member for Chelmsford (Sir Simon Burns), I pay tribute to some of the research and development that has been done by the pharmaceutical industry. Europe has become the biggest research network in the world, and the biggest beneficiary of that has been the United Kingdom, through Horizon 2020 funding, in collaboration with others, and the European Medicines Agency. As others have said, however, both of those are going to change, so the pharmaceutical industry in this country will be rather nervous and anxious about its future Obviously, every new drug that the industry discovers creates an additional cost pressure for the NHS, hence the reason for the pharmaceutical price regulation scheme, which has existed since the 1950s. The current scheme has been in existence since 2014 and has brought significant benefits, as the shadow Minister, the hon. Member for Ellesmere Port and Neston (Justin Madders), has said. In Scotland it directly funds our new medicines and rare diseases fund. Ours is not a cancer drugs fund, so it gives us greater flexibility to treat very rare diseases. The patient’s condition does not need to be cancer, so we are giving Sofosbuvir for hepatitis C and Everolimus for tuberous sclerosis It is necessary, however, to have some form of management over the cost pressure, so the Scottish Government and my colleagues welcome the way in which the Bill tidies up the situation by closing some of the loopholes faced by the NHS. We have heard in particular about those who have a monopoly over generic medicines, whereby companies that are part of the PPRS can charge what they like for them. There needs to be much greater alignment and it needs to apply to all drugs, not just all companies The Secretary of State also mentioned the collection of data. As someone who has worked in the NHS, I have to say that it has struggled with that, and I have concerns about how it will work across the entire NHS, the entire pharmaceutical industry and medical technology and other supplies. We need to make sure that data collection is relatively simple and straightforward, and I also hope that we will bring together and use data that have already been collected I speak as a representative of one of the devolved nations and it is important that our Government are able to access those data easily. The Bill states clearly that the data gathered will be shared with Scottish Ministers, but on what basis? Will it be down to Scottish and Welsh Ministers to request data when they want them, or will they have to wait for an annual return, which might not happen when they want it to happen The Secretary of State said that there had been consultation, but I hope that that will continue, because the devil will be in the detail when it comes to the extension to all medical supplies. Scotland already uses a lot of central procurement to keep costs down, so it is important that the Bill enables, rather than interferes with, that.
Health Service Medical Supplies (Costs) Bill — House of Commons, 2016-10-24
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): Absolutely. We have entered the realms of using immunotherapies such as Herceptin for cancer. Equally, in the mid-2000s, people went to court to try to access that drug, which halves the risk of metastatic disease—and we end up spending much more on patients with that stage of the disease. We give Sofosbuvir in Scotland for hepatitis C because it is almost curative, so we have fewer new hepatitis C patients. We need a much more rounded way of looking at the costs and benefits of new drugs. The genetic drugs that we are likely to use in future will be even more eye-wateringly expensive, but then again, they may have a bigger impact The Bill tidies up loopholes, but I have concerns about the involvement of the devolved Administrations in the design of the schemes, access to data and ensuring that the funding for PPRS, which we use for our new drugs fund, is maintained. There is a call for us to do something much bigger and much more blue skies in future.
Health Service Medical Supplies (Costs) Bill — House of Commons, 2016-10-24
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): Does the right hon. Gentleman recognise that we are one of a tiny handful of OECD countries that allow that opening price to be set completely by the pharmaceutical industry and to be set as high as it likes?
Health Service Medical Supplies (Costs) Bill — House of Commons, 2016-10-24
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): I wonder whether the hon. Lady remembers the time we spent in the House last November debating the Off-patent Drugs Bill. I flagged up the concern that a doctor prescribing a drug with a licence for a use takes precedence over an off-patent drug that may actually be the same. With the sort of gaming we have seen, there is a real concern that drug companies will tweak a drug in the slightest manner and then start selling it to the NHS at hundreds and thousands of pounds, when in actual fact an off-patent drug would do the same job. That has still not been dealt with.
NHS Provision (Brighton and Hove) — House of Commons, 2016-10-24
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): I can see that in this case due diligence was not done in the contract, but is there not an underlying principle that when a piece of NHS service is outsourced the NHS version ceases to exist? Therefore, at some future date, if the service is not good enough or other circumstances change, it is not possible simply to take it back in-house.
Health Service Medical Supplies (Costs) Bill — House of Commons, 2016-12-06
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): There is an additional issue. Drugs or treatments are being passed by NICE but not actually introduced. Either they are rationed and limited to a certain number of patients a month, as is the case with hepatitis C drugs, or the decisions are being left to clinical commissioning groups, which means that we are enshrining postcode prescribing instead of getting rid of it.
Health Service Medical Supplies (Costs) Bill — House of Commons, 2016-12-06
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): Does the Minister accept that it is a slightly bizarre public relations thing to have a medicines fund that is only for cancer, ruling out people with other life-threatening illnesses? That is the case here in England.
Medical Innovation Bill [HL] — House of Lords, 2015-01-23
Topic: Health
Hugh Dykes (Liberal Democrats, Centre to centre-left): I hope my memory is not at fault when I recall that I have attended all the previous stages of this Bill but deliberately not spoken because I preferred as a lay man to listen to what the medical experts were saying. We have had considerable testimony from them in the previous stages which has helped us make progress. I thank the noble Lord, Lord Saatchi, again. I know it has been done before but it is important to record our thanks for his introduction of this extremely interesting legislation, which will be very useful and important to humanity in the future—although it is difficult at this early stage to tell exactly how it will develop and the noble Lord, Lord Pannick, is right in expressing certain reservations about it We all have experience of the sufferings of friends and families in cancer cases and the Bill, not only in a moving way but in a scientifically respectable way, makes progress in widening the ability of medical experts, operating under the strict safeguards that have been agreed in the previous stages, to make sure that people can be helped more than the already marvellous help that doctors give within the existing framework. I am glad to support the amendment.
Brexit: Movement of People in the Cultural Sector (European Union Committee Report) — House of Lords, 2019-05-15
Topic: Culture
Dafydd Wynne Wigley (Plaid Cymru, Centre-left to left): My Lords, I will speak briefly in the gap. It is a delight to follow the noble Duke, the Duke of Somerset. I endorse his comments, particularly on the premature red lines, which many of us feel very strongly about. I again declare my interests: my close family are all employed in the cultural sector. My wife, Elinor Bennett, organises an international harp festival I thank the noble Lord, Lord Jay, and his committee for their excellent report. I apologise for raising prematurely at Question Time the issue of securing agreement on touring visas for those employed in the cultural sector. It was remiss of me to do so ahead of the debate and it put the Minister into a rather invidious position. I am sorry that I did that I draw the House’s attention to an example of the negative impact of artificial barriers on performing artists. NoFit State—that is its name, not a description—is Wales’s flagship contemporary circus company of performing artists. The revenues from international touring accounted for 40% of its turnover in 2016. Its recent experience of touring America highlights the additional costs when there is no barrier-free right to travel and perform. Its costs over and above travel costs for a few weeks in the United States were £46,000 higher than the equivalent costs of a similar tour in the European Union, on the same scale and of the same cultural nature. Major costs included visas for £13,000, carnets for £9,000, and medical and equipment insurance, as well as other significant costs such as certification If costs such as these were to arise relating to working in the EU, it would be totally prohibitive to companies and individuals. They need to know now what the circumstances will be so that they can plan ahead. I agree with the noble Earl, Lord Clancarty, who mentioned an urgent need for the provision of practical information with regard, for example, to visas, permits and carnets for those in the UK cultural sector when they hope to work in the European Union—and indeed for EU performers wishing to come to tour in the UK and the agents organising such visits and activities. A service providing information and assistance of this sort is desperately needed. I hope the Government will be able to say something about that Incidentally, we have seen the difficulties faced by non-EU performers coming to the Llangollen International Eisteddfod, many of whom have faced bureaucratic hurdles. Heaven help us if similar and unnecessary barriers are placed between the European Union and the United Kingdom.
Health and Care Bill — House of Lords, 2022-03-03
Topic: Health
Jennifer Jones (Green Party, Left): My Lords, I am implacably opposed to privatisation of the NHS—not for ideological reasons, although the Green Party is strongly opposed as well. I think it is inefficient. Privatisation has not worked. It has failed to deliver on promises to increase quality, decrease cost and help patients. Rather than save money through reduced bureaucracy, the main cost savings of privatisation seem to be in cutting the terms and conditions—chiefly the pay and pensions—of staff. If private companies can compete for public services, let them compete on a level playing field, rather than simply capturing staff and paying them less I am pleased that the noble Lord, Lord Lansley, explained his Amendment 98 because I had understood it completely the other way around—that he was protecting private services. I was going to have a word with him afterwards about it, but there is now no need As the noble Lord, Lord Hendy, just said, most people in Britain do not want a privatised NHS. They want a public service because that is what will give them the best results.
Deaths in Police Custody — House of Lords, 2017-10-30
Topic: Health
Peter Forster (Bishops, Unknown): My Lords, I very much welcome the report; I have simply read the executive summary. It is obviously important to respond well after death occurs, but equally, arguably, it is even more important to put in place measures to reduce the possibility of death. This is where the healthcare provision in the police service is especially important. Given that the NHS has a direct responsibility to provide healthcare in prisons but does not have an equivalent responsibility for those in police care, and given that for half the people the cause of death is alcohol and drug-related, is there not a need to join up A&E, the police, the whole NHS and police support? It is no doubt complex, but at the heart of this lies quite a simple issue. This ought to be brought within the ambit of the NHS, which is the case with prisons.
Covid-19 — House of Lords, 2022-01-20
Topic: Health
Sarah Mullally (Bishops, Unknown): My Lords, I thank the noble Baroness for her update. I believe that NHS staff who have not received two doses of the vaccine face dismissal from 1 April onwards. It is estimated that this will result in London losing something like 12.5% of its midwives, putting at risk the lives of pregnant women and their babies. Such a loss of staff may be thought to be justified were it not for the case that two doses of the vaccine are not understood to protect against the omicron variant of Covid-19. We shall lose precious midwives to implement a policy that has been superseded by the evolution of the virus. Will Her Majesty’s Government put the implementation of existing legislation on hold, given that it may now lead only to harm and not the good that it was designed to promote?